News for Phio Pharmaceuticals Corp. (PHIOW)

Positive interim results from Phase 1b trial for PH-762 in skin cancer treatment Strategic leadership changes to enhance business development for INTASY

Phio Pharmaceuticals (PHIO) will be participating in the Sidoti Micro-Cap Virtual Investor Conference on May 21-22, 2025. CEO Robert Bitterman will present

Phio Pharmaceuticals (PHIO) reports a 44% complete response rate in its Phase 1b trial for PH-762. Cash reserves increased to $13.3 million by the end of Q1

Phio Pharmaceuticals (PHIO) reports promising results in Phase 1b clinical trial for PH-762, a skin cancer treatment. 4 of 9 cutaneous squamous cell car

Phio Pharmaceuticals (PHIO) to participate in Renmark Financial's Virtual Non-Deal Roadshow on May 7, 2025. CEO Robert Bitterman will discuss advancements

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.29% to 37,535.75 whi...

Phio Pharmaceuticals Corp. (PHIO) progresses with its Phase 1b trial, eyeing enhanced immune responses for skin cancer treatment. Analysts project a sig

Key Highlights: Phio Pharmaceuticals has advanced its Phase 1b trial for PH-762 with favorable early safety results. Analysts predict a significant upsid

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow tra...

Phio Pharmaceuticals (PHIO) advances to the fourth dose escalation cohort in the Phase 1b trial of PH-762 for skin cancer. No serious adverse events or

Florida- based Safe & Green Holdings Corp. (SGBX) is up over 155 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.52%

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 200 points on Tuesday. The Dow traded up 0.50% to 42,509.79 whi...

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday. The Dow traded down 0.21% to 42,216.81 whil...

Phio Pharmaceuticals stock drops 39.1% after announcing a $3.19 million direct offering and concurrent private placement.

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded up...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.85%

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 150 points on Monday. The Dow traded up 0.64% to 42,206.46 while t...

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.13% to 41,992.95 while the NA...